Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Knight Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $601.68M | $586.82M - $615.67M | $81.80M | $0.351 | 3 |
| Dec 2029 | $579.65M | $565.33M - $593.12M | $78.81M | $0.311 | 5 |
| Dec 2028 | $549.61M | $536.04M - $562.39M | $74.72M | $0.291 | 2 |
| Dec 2027 | $529.45M | $509.85M - $548.82M | $71.98M | $0.211 | 6 |
| Dec 2026 | $522.21M | $515.83M - $527.29M | $71.00M | $0.185 | 7 |
| Dec 2025 | $435.18M | $432.83M - $440.62M | $59.17M | -$0.124 | 6 |
| Dec 2024 | $361.31M | $356.94M - $364.73M | $49.12M | -$0.051 | 7 |
| Dec 2023 | $332.73M | $328.91M - $337.07M | $46.75M | $0.058 | 6 |
| Dec 2022 | $272.22M | $268.94M - $275.61M | $38.25M | -$0.188 | 2 |
| Dec 2021 | $248.87M | $245.88M - $251.98M | $34.97M | $0.202 | 5 |
| Dec 2020 | $192.92M | $190.60M - $195.33M | $27.11M | $0.237 | 3 |
| Dec 2019 | $43.07M | $42.55M - $43.61M | $6.05M | $0.183 | 3 |